436 The Prospective Epidemiologic Risk Factor (PERF I) Study: A novel prognostic serum biomarker reflecting type I collagen degradation is associated with tumor burden

Autor:	C. Christiansen, Stephanie Nina Kehlet, Nicholas Willumsen, Jesper Neergaard, H.B. Hansen, K. Dragsb, D.J. Oersnes-Leeming, Morten A. Karsdal, Cecilie L. Bager, Anne-Christine Bay-Jensen
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty Serum biomarkers business.industry Internal medicine Immunology Tumor burden medicine Risk factor business Type I collagen
Zdroj:	European Journal of Cancer. 51:S90-S91
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(16)30270-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::577c10b78b8d7966b7a3a03366c775d3 https://doi.org/10.1016/s0959-8049(16)30270-2 Zobrazit plný text záznamu Full Text from ScienceDirect